Omada Health, Inc. financial data

Symbol
OMDA on Nasdaq
Location
611 Gateway Blvd., Suite 120, South San Francisco, CA
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.6M shares
Common Stock, Shares, Outstanding 57.3M shares
Common Stock, Value, Issued 56K USD
Weighted Average Number of Shares Outstanding, Basic 22M shares +187%
Weighted Average Number of Shares Outstanding, Diluted 22M shares +187%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 61.4M USD +48.9%
Cost of Revenue 21.1M USD +28.6%
Research and Development Expense 10M USD +11.5%
Selling and Marketing Expense 22.3M USD +46.9%
General and Administrative Expense 12.3M USD +15.1%
Operating Income (Loss) -4.34M USD +56.7%
Nonoperating Income (Expense) -967K USD -47.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.31M USD +50.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.31M USD +50.3%
Earnings Per Share, Basic -0.24 USD/shares +82.9%
Earnings Per Share, Diluted -0.24 USD/shares +82.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 223M USD
Accounts Receivable, after Allowance for Credit Loss, Current 33.3M USD
Inventory, Net 3.47M USD
Assets, Current 271M USD
Property, Plant and Equipment, Net 6.48M USD
Operating Lease, Right-of-Use Asset 65K USD
Intangible Assets, Net (Excluding Goodwill) 3.29M USD
Goodwill 13.2M USD
Other Assets, Noncurrent 234K USD
Assets 303M USD
Accounts Payable, Current 7.4M USD
Accrued Liabilities, Current 25.1M USD
Contract with Customer, Liability, Current 25.5M USD
Liabilities, Current 58M USD
Other Liabilities, Noncurrent 373K USD
Liabilities 88.8M USD
Retained Earnings (Accumulated Deficit) -459M USD
Stockholders' Equity Attributable to Parent 214M USD
Liabilities and Equity 303M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 750M shares
Common Stock, Shares, Issued 57.3M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 223M USD +165%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.31M USD +50.3%
Operating Lease, Liability, Current 0 USD
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 673M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.83M USD +36.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares